Published date: 24 October 2023

Last edited date: 24 October 2023

This notice was replaced on 24 October 2023

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Opportunity (published 24 October 2023, last edited 24 October 2023)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

WA7 2ES

Value of contract

£909,933,000

Procurement reference

CF-1922000D0O000000rwimUAA

Published date

24 October 2023

Closing date

23 November 2023

Closing time

1pm

Contract start date

1 March 2024

Contract end date

31 August 2026

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

Offer reference number: CM/PHR/22/5678

CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

More information

Previous notice about this procurement

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

  • Opportunity
  • Published 24 October 2023, last edited 24 October 2023

Attachments

Additional text

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.

Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:

Phone: 0800 9956035

E-mail: support-health@atamis.co.uk

About the buyer

Contact name

Collette Patrick

Address

NHS England
Runcorn
WA7 2ES
GB

Email

collette.patrick@nhs.net